scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1464-410X.2012.11547.X |
P698 | PubMed publication ID | 23046147 |
P50 | author | Kristian Vinter Juul | Q45329296 |
P2093 | author name string | Osamu Yamaguchi | |
Osamu Nishizawa | |||
Jens Peter Nørgaard | |||
P2860 | cites work | Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. | Q43993185 |
Diurnal variation in the levels of antidiuretic hormone in the elderly | Q44357373 | ||
Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women | Q44637304 | ||
Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial | Q48252319 | ||
Nocturnal polyuria in patients with lower urinary tract symptoms and response to alpha-blocker therapy | Q48498566 | ||
Multifactorial nature of male nocturia | Q48510065 | ||
Gender difference in antidiuretic response to desmopressin. | Q51497693 | ||
X-inactivation profile reveals extensive variability in X-linked gene expression in females | Q22122481 | ||
The effect of nocturia on sleep | Q24632849 | ||
The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society | Q28215611 | ||
Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms | Q28289969 | ||
X inactivation, female mosaicism, and sex differences in renal diseases | Q37151640 | ||
Desmopressin 30 years in clinical use: a safety review | Q37239503 | ||
Nocturia: a non-specific but important symptom of urological disease | Q37396037 | ||
Nocturia research: current status and future perspectives | Q37739968 | ||
The prevalence and causes of nocturia | Q37771607 | ||
Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? | Q37868803 | ||
Correlates for nocturia: a review of epidemiological studies | Q37975258 | ||
Antidiuretic hormone in elderly male patients with severe nocturia: a circadian study | Q38516610 | ||
Clinical guidelines for nocturia | Q43087475 | ||
P433 | issue | 3 | |
P921 | main subject | nocturia | Q1426443 |
desmopressin | Q241006 | ||
placebo | Q269829 | ||
P304 | page(s) | 474-484 | |
P577 | publication date | 2012-10-09 | |
P1433 | published in | BJU International | Q4835773 |
P1476 | title | Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial | |
P478 | volume | 111 |
Q46041029 | A practical approach to the management of nocturia |
Q47750340 | Desmopressin for treating nocturia in men. |
Q48504091 | Diagnostic and therapeutic recommendations for patients with nocturia. |
Q92522643 | Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double-blind placebo-controlled parallel-group |
Q38907923 | Nocturia: aetiology and treatment in adults |
Q47999314 | Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study |
Q38227703 | The evaluation and management of persistent nocturia |
Q47696149 | Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia. |
Search more.